The trophinin-associated protein regulated by TROAP, has been correlated to aggressive clinico-pathological features including tumour high grade and mitotic rate [70], while the gene UBE2C has been previously recognised as a prognostic marker for high-risk breast cancer patients [71]. This evidence concerns the gene UBE2C and neoplasm.